Molson Coors Beverage (TAP) Stock

TAP is growing its range of non-alcoholic drinks by forming a strategic partnership and investing in Fever-Tree, with the aim of increasing its presence in the U.S. market.

Molson Coors (TAP) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.

No matter if you invest in value, growth, or momentum stocks, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the best features of the Zacks Premium research service.

TAP's plan for revitalization demonstrates its strength in facing challenges from the U.S., showing significant growth in earnings and potential for global expansion.

On Friday, the U.S. surgeon general released a new advisory about the relationship between drinking alcohol and a higher risk of cancer. Dr. Vivek Murthy, the surgeon general, suggested adding warnings to labels about this connection.

After a slow summer, the U.S. beer market is starting to show positive trends, as reported by Needham.

TAP's plan for revitalization, focus on premium products, and potential for global growth demonstrate strength. Nevertheless, there are worries due to difficulties in the United States market.

TAP is making great strides with its Acceleration Plan. The company's efforts to refresh its strategy and enhance its global offerings are also promising.

TAP's Q3 results have been affected by a tough U.S. economy, which has caused a decrease in financial activity. However, the units in EMEA&APAC and Canada have performed well.